-

Eurofins Environment Testing Launches PFAS Exposure Self-Collection Blood Test

LUXEMBOURG--(BUSINESS WIRE)--Per- and Polyfluorinated Alkyl Substances (PFAS), such as PFOA and PFOS, known as “forever chemicals”, characteristically resist natural breakdown in the environment and human bodies. The US Centers for Disease Control and Prevention (CDC) reports that exposure to these chemicals may cause adverse health effects.

In a leap forward for PFAS identification through blood testing, Eurofins (Paris:ERF) Environment Testing and its research partners have developed a self-administered sampling kit, PFAS Exposure™. The kit is the first of its kind and uses a simple finger prick. To date, testing for PFAS in blood has relied on serum as an estimation for whole blood and required a blood draw conducted by a healthcare practitioner.

Knowledge of PFAS levels in blood can assist in understanding PFAS exposure from one’s occupation, food, drinking water, indoor air, and consumer products such as cookware and clothing and the environmental effects this has on humans.

Eurofins’ PFAS Exposure™ collection kits are an all-in-one solution that include the essentials for collection and transport, allowing participants to self-collect samples at home or work, and submit them directly to the laboratory.

The PFAS Exposure kit is available through Eurofins’ at-home health testing business, empowerDX. Kits can be purchased online for $399 and are shipped directly to the customers home or business.

Increasing knowledge of PFAS in blood

Eurofins will provide data for 47 PFAS compounds in whole blood, expanding on the CDC National Health and Nutrition Examination Survey (NHANES) study and database where 16 PFAS compounds in serum are reported.

Further information: www.EurofinsPFAS.com

About Eurofins Environment Testing America

The Eurofins Environment Testing network in the US contributes to a clean and safe environment by providing market-leading laboratory testing, monitoring, and consulting services to a wide range of industrial companies, environmental consultants, contractors, retailers and government authorities.

About empowerDX

empowerDX is the online shop for easy at-home health testing. empowerDX specializes in FDA-authorized COVID-19 testing, women’s health, men’s health, sexual health and general wellness testing. empowerDX is positioned to lead the market for cutting edge, self-collected diagnostic and non-diagnostic testing.

To learn more: empowerdxlab.com

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With 55,000 staff across a network of 900 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.

Contacts

Brian Williams
ir@eurofins.com

Eurofins

BOURSE:ERF

Release Versions

Contacts

Brian Williams
ir@eurofins.com

More News From Eurofins

Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the integration of advanced, custom-built Continuous Flow (CF) technology to its operations. The company is receiving advisory services and research and development funding support from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) for this project. Developed in-house by Euro...

Eurofins to Divest Its Electrical & Electronic Testing Business

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (the “Company” or “Eurofins”) (EUFI.PA) (Paris:ERF) announces the signing of an agreement to divest its Electrical & Electronic Testing business (“MET Labs”) to UL Solutions Inc. for an Enterprise Value of €575 million on a cash and debt free basis. MET Labs is expected to generate over €180 million in revenues in 2026, with profitability broadly in line with the Group average, and employs approximately 1,300 staff globall...

Eurofins Scientific SE: Weekly report on Share Repurchases on 30th March 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 30/03/2026 FR0014000MR3 4 186 61.7620 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 30/03/2026 FR0014000MR3 1 290 61.7857 CEUX       TOTAL 5 476 61.7676   Trans...
Back to Newsroom